Literature DB >> 32732345

Intraocular pressure and circumpapillary retinal nerve fibre layer thickness in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA): distributions and associations.

Paul McCann1, Ruth Hogg1, David M Wright1, Usha Chakravarthy1, Tunde Peto1, Sharon Cruise1, Bernardette McGuinness1, Ian S Young1, Frank Kee1, Augusto Azuara-Blanco2.   

Abstract

AIMS: To describe the distributions of and associations with intraocular pressure (IOP) and circumpapillary retinal nerve fibre layer (cRNFL) thickness in a population-based study.
METHODS: Northern Ireland Cohort for the Longitudinal Study of Ageing participants underwent a computer-assisted personal interview, a self-completion questionnaire and a health assessment (HA). At the HA, participants underwent IOP measurement using Ocular Response Analyser and spectral-domain optical coherence tomography with Heidelberg Spectralis. Participants also underwent a range of anthropometric, ophthalmic, cardiovascular, cognition and blood tests. Participants who attended the HA and had a vertical cup-to-disc ratio (VCDR) measurement in at least one eye were eligible for the study. Participants without any IOP or cRNFL measurements were excluded from the respective analyses.
RESULTS: There were 3221 participants eligible for this study (5753 eyes included in the IOP analysis and 5461 eyes included in the cRNFL analysis). The mean (SD) Goldmann correlated IOP (IOPg) was 15.39 mm Hg (3.55 mm Hg). The mean (SD) average global cRNFL thickness was 94.39 µm (11.18 µm). Increased IOPg was associated with increased age, male sex, hypertension, refractive error (myopic decrease in spherical equivalent) and increased corneal resistance factor, while beta-blocker drug use was associated with lower IOPg in the fully adjusted multivariate analysis. Thinner average global cRNFL was associated with Alzheimer's disease in the age-adjusted and sex-adjusted model. In the fully adjusted multivariate analysis, increased age, male sex, left eyes, hypertension, increased VCDR, refractive error (myopic decrease in spherical equivalent) and increased IOPg were associated with thinner average global cRNFL, while Parkinson's disease and current (vs never) smoking status were associated with thicker average global cRNFL.
CONCLUSIONS: Increased IOP and reduced cRNFL were associated with increased age, myopic refractive error, male sex and hypertension. Alzheimer's disease was associated with thinner average global cRNFL, while Parkinson's disease was associated with thicker average global cRNFL. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Anatomy; Diagnostic tests/Investigation; Glaucoma; Intraocular pressure; Retina

Year:  2020        PMID: 32732345     DOI: 10.1136/bjophthalmol-2020-316499

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  3 in total

1.  Comparison of Non-contact Tonometry and Goldmann Applanation Tonometry Measurements in Non-pathologic High Myopia.

Authors:  Peiyuan Wang; Yunhe Song; Fengbin Lin; Zhenyu Wang; Xinbo Gao; Weijing Cheng; Meiling Chen; Yuying Peng; Yuhong Liu; Xiulan Zhang; Shida Chen
Journal:  Front Med (Lausanne)       Date:  2022-03-03

2.  Reading cognition from the eyes: association of retinal nerve fibre layer thickness with cognitive performance in a population-based study.

Authors:  Johanna Girbardt; Tobias Luck; Jana Kynast; Francisca S Rodriguez; Barbara Wicklein; Kerstin Wirkner; Christoph Engel; Christian Girbardt; Mengyu Wang; Maryna Polyakova; A Veronica Witte; Markus Loeffler; Arno Villringer; Steffi G Riedel-Heller; Matthias L Schroeter; Tobias Elze; Franziska G Rauscher
Journal:  Brain Commun       Date:  2021-11-08

3.  Lowering Intraocular Pressure: A Potential Approach for Controlling High Myopia Progression.

Authors:  Peiyuan Wang; Shida Chen; Yaoming Liu; Fengbin Lin; Yunhe Song; Tuozhang Li; Tin Aung; Xiulan Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-11-01       Impact factor: 4.799

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.